Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population

Genes Immun. 2011 Oct;12(7):552-8. doi: 10.1038/gene.2011.32. Epub 2011 May 19.

Abstract

The role of host genetic factors in the pathogenesis and outcome of hepatitis B virus (HBV) infection is not well known. We assessed the association of HLA and TNF (rs361525, rs1800629, rs1799724, rs1800630 and rs1799964) polymorphisms with HBV outcome in the South Indian population. Association of HLA polymorphism was analyzed in 90 individuals from each group, that is, spontaneous recovery (SR) and chronic-HBV (C-HBV) infection. The role of TNF polymorphisms was evaluated in 150 subjects with SR and 137 patients with C-HBV infection. After adjusting for age and sex, HLA-DRB1*07:01 was strongly associated with chronicity (corrected P-value (pc) <0.005, odds ratio (OR) 3.76, 95% confidence interval (CI) 1.84-7.68). The rs1800630 genotype was associated with HBV outcome in codominant (pc<0.01, OR=1.99, 95% CI 1.30-3.05) and dominant (pc<0.01, OR=2.28, 95% CI 1.35-3.84) analyzing models after adjusting for age and sex. Similarly, the rs1799964 genotype was associated with HBV outcome in codominant (pc=0.01, OR=1.57, 95% CI 1.09-2.27) and dominant (pc<0.01, OR=2.21, 95% CI 1.27-3.83) analyzing models. Haplotype analysis (rs1799964/rs1800630/rs1799724/rs1800629/rs361525) revealed that the CACGG haplotype was strongly associated with C-HBV infection (P=0.0004). Our study suggests that inheritance of HLA and TNF polymorphisms might explain the outcome of HBV infection in the South Indian population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Asian People / genetics
  • Female
  • Gene Frequency
  • Genotype
  • HLA Antigens / genetics*
  • HLA-DRB1 Chains / genetics
  • Hepatitis B / genetics*
  • Hepatitis B, Chronic / genetics
  • Humans
  • India
  • Linkage Disequilibrium
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Tumor Necrosis Factor-alpha / genetics*
  • Young Adult

Substances

  • HLA Antigens
  • HLA-DRB1 Chains
  • Tumor Necrosis Factor-alpha